Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis

Eitemau Tebyg

• Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis
  gan: Fahrbach, Kyle, et al.
  Cyhoeddwyd: (2020)
• Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families
  gan: Simpson, Eric L., et al.
  Cyhoeddwyd: (2018)
• Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic dermatitis
  gan: Eichenfield, Lawrence F., et al.
  Cyhoeddwyd: (2020)
• Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups
  gan: Callender, Valerie D., et al.
  Cyhoeddwyd: (2019)
• Crisaborole for atopic dermatitis
  Cyhoeddwyd: (2019)